未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 Orally active oxime derivatives of the dopaminergic prodrug 6-(N,N-Di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one.: Synthesis and pharmacological activity
Venhuis, BJ; Dijkstra, D; Wustrow, D; Meltzer, LT; Wise, LD; Johnson, SJ; Wikström, HV 分享 收藏 Orally active analogues of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one:: Synthesis and pharmacological activityVenhuis, BJ; Dijkstra, D; Wustrow, DJ; Meltzer, LT; Wise, LD; Johnson, SJ; Heffner, TG; Wikström, HV 分享 收藏 A new type of prodrug of catecholamines:: An opportunity to improve the treatment of Parkinson's disease (vol 45, pg 2349, 2002)Venhuis, BJ; Rodenhuis, N; Wikström, HV; Wustrow, D; Meltzer, LT; Wise, LD; Johnson, SJ; Pugsley, TA; Sundell, S; Dijkstra, D 分享 收藏 THE DISCOVERY AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 1,2,3,6-TETRAHYDRO-4-PHENYL-1-[(ARYLCYCLOHEXENYL)ALKYL]PYRIDINES - DOPAMINE AUTORECEPTOR AGONISTS AND POTENTIAL ANTIPSYCHOTIC AGENTSWRIGHT, JL; CAPRATHE, BW; DOWNING, DM; GLASE, SA; HEFFNER, TG; JAEN, JC; JOHNSON, SJ; KESTEN, SR; MACKENZIE, RG; MELTZER, LT; PUGSLEY, TA; SMITH, SJ; WISE, LD; WUSTROW, DJ 分享 收藏 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
